Document Detail


Cardiogenic shock: management of right ventricular infarction shock.
MedLine Citation:
PMID:  22495165     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Right ventricular infarction is a not uncommon cause of cardiogenic shock, whose frecuency is variable and could be underestimated. Although left ventricular myocardial management is well defined in the right ventricular infarction are few studies with low level of evidence, to establish definitive guidelines. It is assumed that the treatment is similar to that of the left ventricle, although there are some differences. The axis of the therapeutic management, as well as the left ventricle infarction, is based on early myocardial reperfusion, particularly through percutaneous coronary interventionism. Throm-bolysis is an option, especially after an increase in systemic blood pressure using vasoactive drugs such as norepinephrine. The preload optimization by volume administration during resuscitation of shock is useful, but it must be with caution. The use of levosimendan could be potentially beneficial option. On the neurohormonal modulation of systemic inflammatory response produced after the cardiogenic shock (CS), the use of ACE inhibitors and beta-blockers is controversial.
Authors:
M Ruiz Bailén; M I Ruiz García; A Ferrezuelo Mata; R Quirós Barrera
Related Documents :
8681315 - Interruption of the progression of heart failure: are ace inhibitors the solution?
7852915 - Heart failure: a growing public health problem.
19041835 - Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with he...
12439425 - Acutely decompensated heart failure: opportunities to improve care and outcomes in the ...
15494585 - Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peri...
1760185 - Induction of wide qrs tachycardia during transthoracic echocardiography.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Minerva cardioangiologica     Volume:  60     ISSN:  0026-4725     ISO Abbreviation:  Minerva Cardioangiol     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400725     Medline TA:  Minerva Cardioangiol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  167-74     Citation Subset:  IM    
Affiliation:
Department of Health Science, Jaén University, Jaén, Spain - ruizbailen@telefonica.net.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Saphenous vein graft interventions: strategies and devices to minimize distal embolization.
Next Document:  The role of B-type natriuretic peptide testing in patients with acute coronary syndromes.